Machine Perfusion Across Solid Organ and Vascularized Composite Allograft Transplantation: Updates from the 2026 American Transplant Congress
Year: 2026
Type: article
Abstract: The 2026 American Transplant Congress, jointly organized by the American Society of Transplant Surgeons and the American Society of Transplantation, highlighted the expanding role of machine perfusion (MP) in broadening the donor pool across liver, kidney, lung, heart, and vascularized composite allograft transplantation. Of 106 relevant abstracts identified, 39 with the greatest clinical and translational relevance were selected for discussion. Across organ systems, normothermic and hypothermic MP facilitated utilization of higher-risk grafts, including donation-after-circulatory-death, steatotic, and extended-criteria organs, with early outcomes comparable or superior to static cold storage. Normothermic regional perfusion emerged as a complementary preconditioning strategy, particularly in reducing biliary complications after liver transplantation and delayed graft function after kidney transplantation. Novel biomarkers, including perfusate flavin mononucleotide, and integrated biochemical, physiologic, and histologic panels showed promise for real-time graft viability assessment. Emerging approaches, including 7-day liver preservation, ischemia-free liver transplantation, gaseous cardiac perfusion, and ex situ modeling of T-cell-mediated rejection, further suggest that MP is evolving into a therapeutic and investigative platform. Important limitations include variable benefits across recipient risk profiles, cardiac size-matching constraints, and disparities in access to normothermic liver perfusion. Multicenter validation, equitable access, and organ- and risk-specific strategies will be essential to realize the full potential of MP in transplantation.
Source: Surgeries
Institutions: University of Oklahoma Medical Center, University of Oklahoma
Language: English
Subfield: Surgery
Field: Medicine
Domain: Health Sciences
Keywords: machine perfusion, solid organ transplantation, hypothermic machine perfusion, donation after circulatory death, extended criteria donors, normothermic regional perfusion, biliary complications, delayed graft function, graft viability assessment, T cell-mediated rejection, donor pool expansion
Open Access status: gold
Estimated APC paid: $1,448
OpenAlex ID: W7234922598
